Daniel Wallerstorfer

I studied Molecular Biology (Bsc) and Biotechnology (PhD) at the University of Manchester and founded my first Biotech Startup, Novogenia in 2009. Novogenia built a high tech medical genetic laboratory and developed new technologies in the field of personalization of Supplements and cosmetics. With more than 180 employees, Novogenia became Austria's largest COVID PCR laboratory during the COVID-Pandemic.

In 2018, I co-founded the american Startup Rootine Vitamins, that was accepted into the Techstars accelerator Program in New York. Rootine is a rapidly growing B2C company that provides genetic, blood and Lifestyle Analyses coupled with personalized Supplements to American customers.

In 2021, my first Book on Nutrigenetics and preventive genetics is published by the BASTEI LÜBBE Publisher.

My interests are Medical genetics, Nutrigenetics, Biotech, Personalization of nutritional supplements and cosmetics, Life extension, Paleontology, Genetic engineering and (preimplantation) genetic testing.